952-P: Deranged Liver Enzyme Levels and Indices of Hepatic Steatosis and Fibrosis on the Development of Gestational Diabetes

Objective: Nonalcoholic fatty liver disease has been associated with the development of gestational diabetes (GDM). We sought to determine whether abnormal liver enzyme levels and indices of hepatic steatosis and fibrosis in an entire pregnant population are associated with GDM development. Methods:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser:	CHAI, THORA Y.L., PASUPATHY, DHARMINTRA, GEORGE, JACOB, CHEUNG, N. WAH
Format:	Artikel
Sprache:	eng
Schlagworte:	Alanine Alkaline phosphatase Bilirubin Body mass index Diabetes mellitus Enzymes Fatty liver Fibrosis Gestational diabetes Glucose tolerance Liver Liver diseases Steatosis γ-Glutamyltransferase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	Supplement_1
container_start_page
container_title	Diabetes (New York, N.Y.)
container_volume	70
creator	CHAI, THORA Y.L. PASUPATHY, DHARMINTRA GEORGE, JACOB CHEUNG, N. WAH
description	Objective: Nonalcoholic fatty liver disease has been associated with the development of gestational diabetes (GDM). We sought to determine whether abnormal liver enzyme levels and indices of hepatic steatosis and fibrosis in an entire pregnant population are associated with GDM development. Methods: A retrospective cohort study was conducted on adult women (≥18 years) who delivered at 2 teaching hospitals in Sydney Australia from January 2016 to December 2017. Liver enzymes (aspartate aminotransaminase (AST), alanine aminotransaminase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin (ALB) and bilirubin (BIL)) obtained 12 months pre-gravid, or during pregnancy but prior to GDM screening, were extracted from the hospital pathology database and linked with oral glucose tolerance test results. The Fibrosis-4 (FIB-4) and Hepatic Steatosis Index (HSI) were calculated. Univariate analysis was undertaken to determine the association between deranged liver enzymes, FIB-4, HSI and GDM. Multiple logistic regression, with adjustment for age, ethnicity, pre-gravid body mass index (BMI), parity, prior GDM and family history of diabetes, was conducted to determine if any of these were independent predictors of GDM. Results: Over 2 years, 1429 women had liver enzymes collected. As per IADPSG (2010) criteria, 255 had diagnosed GDM, of which 82 (32.2%) were obese (BMI >30kg/m2), 243 (82.4%) were multiparous, and 223 (87.5%) had prior GDM. Elevated GGT (>35IU/L, p=0.006) and HSI (p=0.005) were associated with development of GDM, whilst low ALB (110IU/L), ALT (>35IU/L), AST (>35IU/L), BIL (>19umol/L) and FIB-4 were not. On adjustment for confounders, elevated GGT (AOR 1.1, 95% CI 0.32-3.8, p=0.88) and HSI (AOR 0.6, 95% CI 0.26-1.3, p=0.21) were not independent predictors of GDM. Conclusions: Our results indicate deranged liver enzymes or clinical indices of hepatic steatosis and fibrosis were not associated with GDM.
doi_str_mv	10.2337/db21-952-P
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2562269033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2562269033</sourcerecordid><originalsourceid>FETCH-LOGICAL-c633-bf47cabe92a04c3a9e6af7e9dbda1a6cfdcabab179cde62c8f266c7a97bcf6b93</originalsourceid><addsrcrecordid>eNotUE1LAzEUDKJgrV78BQFvQjSbtInxJrVfsGDBHryFfLzolnZ3TbaFij_etJV3eDzezDAzCN0W9IFxLh-9ZQVRQ0YWZ6hXKK4IZ_LjHPUoLRgppJKX6CqlFaVU5Omh3yP4Gb9CNPUneFxWO4h4XP_sN4BL2ME6YVN7PK995SDhJuAZtKarHH7vwHRNqk6ASWXj8Whq3H1BVszcpt1A3R1IU0hdZjW1WePXyljoIF2ji2DWCW7-dx8tJ-PlaEbKt-l89FISJzgnNgykywTFDB04bhQIEyQob70pjHDB56-xOZzzIJh7CkwIJ42S1gVhFe-ju5NsG5vvbfahV802ZiNJs6FgTCjKeUbdn1Aux0gRgm5jtTFxrwuqD-XqQ7k696UX_A8N6m62</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2562269033</pqid></control><display><type>article</type><title>952-P: Deranged Liver Enzyme Levels and Indices of Hepatic Steatosis and Fibrosis on the Development of Gestational Diabetes</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>CHAI, THORA Y.L. ; PASUPATHY, DHARMINTRA ; GEORGE, JACOB ; CHEUNG, N. WAH</creator><creatorcontrib>CHAI, THORA Y.L. ; PASUPATHY, DHARMINTRA ; GEORGE, JACOB ; CHEUNG, N. WAH</creatorcontrib><description>Objective: Nonalcoholic fatty liver disease has been associated with the development of gestational diabetes (GDM). We sought to determine whether abnormal liver enzyme levels and indices of hepatic steatosis and fibrosis in an entire pregnant population are associated with GDM development. Methods: A retrospective cohort study was conducted on adult women (≥18 years) who delivered at 2 teaching hospitals in Sydney Australia from January 2016 to December 2017. Liver enzymes (aspartate aminotransaminase (AST), alanine aminotransaminase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin (ALB) and bilirubin (BIL)) obtained 12 months pre-gravid, or during pregnancy but prior to GDM screening, were extracted from the hospital pathology database and linked with oral glucose tolerance test results. The Fibrosis-4 (FIB-4) and Hepatic Steatosis Index (HSI) were calculated. Univariate analysis was undertaken to determine the association between deranged liver enzymes, FIB-4, HSI and GDM. Multiple logistic regression, with adjustment for age, ethnicity, pre-gravid body mass index (BMI), parity, prior GDM and family history of diabetes, was conducted to determine if any of these were independent predictors of GDM. Results: Over 2 years, 1429 women had liver enzymes collected. As per IADPSG (2010) criteria, 255 had diagnosed GDM, of which 82 (32.2%) were obese (BMI >30kg/m2), 243 (82.4%) were multiparous, and 223 (87.5%) had prior GDM. Elevated GGT (>35IU/L, p=0.006) and HSI (p=0.005) were associated with development of GDM, whilst low ALB (<35g/L) and elevated ALP (>110IU/L), ALT (>35IU/L), AST (>35IU/L), BIL (>19umol/L) and FIB-4 were not. On adjustment for confounders, elevated GGT (AOR 1.1, 95% CI 0.32-3.8, p=0.88) and HSI (AOR 0.6, 95% CI 0.26-1.3, p=0.21) were not independent predictors of GDM. Conclusions: Our results indicate deranged liver enzymes or clinical indices of hepatic steatosis and fibrosis were not associated with GDM.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db21-952-P</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Alanine ; Alkaline phosphatase ; Bilirubin ; Body mass index ; Diabetes mellitus ; Enzymes ; Fatty liver ; Fibrosis ; Gestational diabetes ; Glucose tolerance ; Liver ; Liver diseases ; Steatosis ; γ-Glutamyltransferase</subject><ispartof>Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)</ispartof><rights>Copyright American Diabetes Association Jun 1, 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>CHAI, THORA Y.L.</creatorcontrib><creatorcontrib>PASUPATHY, DHARMINTRA</creatorcontrib><creatorcontrib>GEORGE, JACOB</creatorcontrib><creatorcontrib>CHEUNG, N. WAH</creatorcontrib><title>952-P: Deranged Liver Enzyme Levels and Indices of Hepatic Steatosis and Fibrosis on the Development of Gestational Diabetes</title><title>Diabetes (New York, N.Y.)</title><description>Objective: Nonalcoholic fatty liver disease has been associated with the development of gestational diabetes (GDM). We sought to determine whether abnormal liver enzyme levels and indices of hepatic steatosis and fibrosis in an entire pregnant population are associated with GDM development. Methods: A retrospective cohort study was conducted on adult women (≥18 years) who delivered at 2 teaching hospitals in Sydney Australia from January 2016 to December 2017. Liver enzymes (aspartate aminotransaminase (AST), alanine aminotransaminase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin (ALB) and bilirubin (BIL)) obtained 12 months pre-gravid, or during pregnancy but prior to GDM screening, were extracted from the hospital pathology database and linked with oral glucose tolerance test results. The Fibrosis-4 (FIB-4) and Hepatic Steatosis Index (HSI) were calculated. Univariate analysis was undertaken to determine the association between deranged liver enzymes, FIB-4, HSI and GDM. Multiple logistic regression, with adjustment for age, ethnicity, pre-gravid body mass index (BMI), parity, prior GDM and family history of diabetes, was conducted to determine if any of these were independent predictors of GDM. Results: Over 2 years, 1429 women had liver enzymes collected. As per IADPSG (2010) criteria, 255 had diagnosed GDM, of which 82 (32.2%) were obese (BMI >30kg/m2), 243 (82.4%) were multiparous, and 223 (87.5%) had prior GDM. Elevated GGT (>35IU/L, p=0.006) and HSI (p=0.005) were associated with development of GDM, whilst low ALB (<35g/L) and elevated ALP (>110IU/L), ALT (>35IU/L), AST (>35IU/L), BIL (>19umol/L) and FIB-4 were not. On adjustment for confounders, elevated GGT (AOR 1.1, 95% CI 0.32-3.8, p=0.88) and HSI (AOR 0.6, 95% CI 0.26-1.3, p=0.21) were not independent predictors of GDM. Conclusions: Our results indicate deranged liver enzymes or clinical indices of hepatic steatosis and fibrosis were not associated with GDM.</description><subject>Alanine</subject><subject>Alkaline phosphatase</subject><subject>Bilirubin</subject><subject>Body mass index</subject><subject>Diabetes mellitus</subject><subject>Enzymes</subject><subject>Fatty liver</subject><subject>Fibrosis</subject><subject>Gestational diabetes</subject><subject>Glucose tolerance</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Steatosis</subject><subject>γ-Glutamyltransferase</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotUE1LAzEUDKJgrV78BQFvQjSbtInxJrVfsGDBHryFfLzolnZ3TbaFij_etJV3eDzezDAzCN0W9IFxLh-9ZQVRQ0YWZ6hXKK4IZ_LjHPUoLRgppJKX6CqlFaVU5Omh3yP4Gb9CNPUneFxWO4h4XP_sN4BL2ME6YVN7PK995SDhJuAZtKarHH7vwHRNqk6ASWXj8Whq3H1BVszcpt1A3R1IU0hdZjW1WePXyljoIF2ji2DWCW7-dx8tJ-PlaEbKt-l89FISJzgnNgykywTFDB04bhQIEyQob70pjHDB56-xOZzzIJh7CkwIJ42S1gVhFe-ju5NsG5vvbfahV802ZiNJs6FgTCjKeUbdn1Aux0gRgm5jtTFxrwuqD-XqQ7k696UX_A8N6m62</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>CHAI, THORA Y.L.</creator><creator>PASUPATHY, DHARMINTRA</creator><creator>GEORGE, JACOB</creator><creator>CHEUNG, N. WAH</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20210601</creationdate><title>952-P: Deranged Liver Enzyme Levels and Indices of Hepatic Steatosis and Fibrosis on the Development of Gestational Diabetes</title><author>CHAI, THORA Y.L. ; PASUPATHY, DHARMINTRA ; GEORGE, JACOB ; CHEUNG, N. WAH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c633-bf47cabe92a04c3a9e6af7e9dbda1a6cfdcabab179cde62c8f266c7a97bcf6b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alanine</topic><topic>Alkaline phosphatase</topic><topic>Bilirubin</topic><topic>Body mass index</topic><topic>Diabetes mellitus</topic><topic>Enzymes</topic><topic>Fatty liver</topic><topic>Fibrosis</topic><topic>Gestational diabetes</topic><topic>Glucose tolerance</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Steatosis</topic><topic>γ-Glutamyltransferase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHAI, THORA Y.L.</creatorcontrib><creatorcontrib>PASUPATHY, DHARMINTRA</creatorcontrib><creatorcontrib>GEORGE, JACOB</creatorcontrib><creatorcontrib>CHEUNG, N. WAH</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHAI, THORA Y.L.</au><au>PASUPATHY, DHARMINTRA</au><au>GEORGE, JACOB</au><au>CHEUNG, N. WAH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>952-P: Deranged Liver Enzyme Levels and Indices of Hepatic Steatosis and Fibrosis on the Development of Gestational Diabetes</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2021-06-01</date><risdate>2021</risdate><volume>70</volume><issue>Supplement_1</issue><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Objective: Nonalcoholic fatty liver disease has been associated with the development of gestational diabetes (GDM). We sought to determine whether abnormal liver enzyme levels and indices of hepatic steatosis and fibrosis in an entire pregnant population are associated with GDM development. Methods: A retrospective cohort study was conducted on adult women (≥18 years) who delivered at 2 teaching hospitals in Sydney Australia from January 2016 to December 2017. Liver enzymes (aspartate aminotransaminase (AST), alanine aminotransaminase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin (ALB) and bilirubin (BIL)) obtained 12 months pre-gravid, or during pregnancy but prior to GDM screening, were extracted from the hospital pathology database and linked with oral glucose tolerance test results. The Fibrosis-4 (FIB-4) and Hepatic Steatosis Index (HSI) were calculated. Univariate analysis was undertaken to determine the association between deranged liver enzymes, FIB-4, HSI and GDM. Multiple logistic regression, with adjustment for age, ethnicity, pre-gravid body mass index (BMI), parity, prior GDM and family history of diabetes, was conducted to determine if any of these were independent predictors of GDM. Results: Over 2 years, 1429 women had liver enzymes collected. As per IADPSG (2010) criteria, 255 had diagnosed GDM, of which 82 (32.2%) were obese (BMI >30kg/m2), 243 (82.4%) were multiparous, and 223 (87.5%) had prior GDM. Elevated GGT (>35IU/L, p=0.006) and HSI (p=0.005) were associated with development of GDM, whilst low ALB (<35g/L) and elevated ALP (>110IU/L), ALT (>35IU/L), AST (>35IU/L), BIL (>19umol/L) and FIB-4 were not. On adjustment for confounders, elevated GGT (AOR 1.1, 95% CI 0.32-3.8, p=0.88) and HSI (AOR 0.6, 95% CI 0.26-1.3, p=0.21) were not independent predictors of GDM. Conclusions: Our results indicate deranged liver enzymes or clinical indices of hepatic steatosis and fibrosis were not associated with GDM.</abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db21-952-P</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0012-1797
ispartof	Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)
issn	0012-1797 1939-327X
language	eng
recordid	cdi_proquest_journals_2562269033
source	Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects	Alanine Alkaline phosphatase Bilirubin Body mass index Diabetes mellitus Enzymes Fatty liver Fibrosis Gestational diabetes Glucose tolerance Liver Liver diseases Steatosis γ-Glutamyltransferase
title	952-P: Deranged Liver Enzyme Levels and Indices of Hepatic Steatosis and Fibrosis on the Development of Gestational Diabetes
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T01%3A16%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=952-P:%20Deranged%20Liver%20Enzyme%20Levels%20and%20Indices%20of%20Hepatic%20Steatosis%20and%20Fibrosis%20on%20the%20Development%20of%20Gestational%20Diabetes&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=CHAI,%20THORA%20Y.L.&rft.date=2021-06-01&rft.volume=70&rft.issue=Supplement_1&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db21-952-P&rft_dat=%3Cproquest_cross%3E2562269033%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2562269033&rft_id=info:pmid/&rfr_iscdi=true